Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine. [electronic resource]
Producer: 20120321Description: 651-9 p. digitalISSN:- 1099-0844
- Anthracyclines -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Azacitidine -- analogs & derivatives
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- DNA Methylation -- drug effects
- Decitabine
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Neoplasm Invasiveness
- Plasminogen Activator Inhibitor 1 -- genetics
- Urokinase-Type Plasminogen Activator -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.